All Supply chains articles
-
JournalThe availability of medicines post-Brexit in Malta
Malta has historically sourced medicinal supplies from the UK, but following Brexit insufficient supply of medicines represents a significant obstacle to patients’ access to medicines.
-
-
-
FocusBrexit − Regulatory and supply chain considerations
The UK formally left the EU on 31 January 2020 and the transition period, as set out in the withdrawal agreement, came to an end on 31 December 2020. During this transition period, the UK continued to remain under EU pharmaceutical law. From 1 January 2021, the UK adopted an ...